LivaNova Plc (LIVN)
LivaNova Market Cap: 3.422B for Dec. 10, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| NovoCure Ltd. | 1.422B |
| Abbott Laboratories | 213.32B |
| ResMed, Inc. | 36.44B |
| Tactile Systems Technology, Inc. | 647.51M |
| Perspective Therapeutics, Inc. | 188.45M |
Market Cap Related Metrics
| PS Ratio | 2.543 |
| Price to Book Value | 2.957 |
| Price to Free Cash Flow | 17.92 |
| Price | 62.67 |
| Earnings Yield | -6.40% |